Technology | 2021.08.02
Moonlight Therapeutics Awarded $1.9M Grant to Advance Development of Peanut Allergy Treatment
Moonlight Therapeutics, Inc., a biotechnology company developing treatments for food allergies, announced the receipt of $1.9 million in funding for preclinical studies and product development that will enable preparations for a clinical trial for its lead program in peanut allergy. This funding was awarded through a Phase 2 Small Business grant from the National Institute of Allergy and Infectious Diseases (NIAID), a division of the National Institutes of Health (NIH).
(PRWeb August 02, 2021)
Read the full story at https://www.prweb.com/releases/2021/08/prweb18095859.htm
For more information, please visit
https://www.prweb.com/releases/2021/08/prweb18095859.htm
